Press release
Immunosuppressant Drug Monitoring Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023
Immunosuppressant Drug Monitoring Market
Immunosuppressant drug monitoring is most vital for monitoring of immunosuppressant drug levels in patients in order to prevent the organ rejection. It is one of the applications of therapeutic drug monitoring, aims to maintain the adequate concentration of drugs in body fluids in order to refine patient care by adjusting individual drug dosage for the better outcomes. Immunosuppressant drugs are known as anti-rejection drugs, which inhibits the activity of immune system that are most commonly used in organ transplantations, auto immune disorders like multiple sclerosis, rheumatoid arthritis and chron’s disease.
Market Dynamics: Immunosuppresant Drug Monitering Market
Growing demand for organ transplantations, advancements in procedures of organ transplantation, growing prevalence of auto immune diseases are expected to witness tremendous growth of the immunosuppressant drug monitoring market. Furthermore, favorable reimbursement policies, growing awareness among the people regarding healthcare and organ transplantations are expected to fuel immunosuppressant drug monitoring market. However, strict regulatory frameworks, availability of alternative therapies like stem cell therapy for immunosuppression are expected to hamper the growth of immunosuppressant drug monitoring market.
A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/immunosuppressant-drug-monitoring-market/#ulp-4H8Z4LpNMLEuOnnx
Market Scope: Immunosuppresant Drug Monitering Market
Immunosuppressant drug monitoring market is segmented on the basis of design, magnetic field strength, application, end user and regions
Based on Product, market is segmented into the following
• Equipment
• Consumables
Based on Technology, market is segmented into the following
• Proteomics Technologies
• Immunoassays
• Electrophoresis
• Spectrometry
Based on Drugs, market is segmented into the following
• Antibodies
• Corticosteroids
• Calcineurin inhibitors
• Anti-proliferative agents
• mTOR inhibitors
• Others
Based on Disease, market is segmented into the following
• Autoimmune disorders
• Organ transplantation
• Non-auto immune inflammatory diseases
Based on the end user, market is segmented into the following:
• Hospitals
• Diagnostic laboratories
• Research Institutes
• Academic Institutes
Based on the region, market is segmented into the following
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/immunosuppressant-drug-monitoring-market/#ulp-c654SbFYO64MsOhu
Market Summary: Immunosuppresant Drug Monitering Market
Immunosuppressant drug monitoring market is growing at a significant rate due to rise in prevalence of autoimmune disorders and organ transplantations. As per WHO statistics, about 119,873 organ transplantation cases were reported in 2014, raised about 1.8% from 2013. Growing prevalence of autoimmune disorders and rise in investments in R&D activities for innovation of new procedures are expected to propel the immunosuppressant drug monitoring market over the forecast timeframe. Moreover, acquisitions and mergers, new product approvals, and product launches are major strategies followed by market players for increasing the revenue in immunosuppressant drug monitoring market.
Regional Analysis: Immunosuppresant Drug Monitering Market
Geographically, global immunosuppressant drug monitoring market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is expected to hold largest share in immunosuppressant drug monitoring market due to rise in prevalence of autoimmune disorders, increase in R&D investments. As per American Autoimmune Related Disease Association, about 50 Mn people suffered from autoimmune diseases in U.S. in 2016. Europe holds second largest position in immunosuppressant drug monitoring market owing to rise in demand for organ transplantation, development of innovative products and favorable regulatory conditions. As per European Commission in 2013, about 31,165 organ transplantation cases were reported in EU-28. Asia Pacific is an emerging region for immunosuppressant drug monitoring market due to increase in medical tourism due to low cost associated with the procedures, geographical expansions by the market players, launch of innovative products, growing prevalence of autoimmune diseases and presence of large patient pool.
Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/immunosuppressant-drug-monitoring-market/#ulp-14mlyhjMGhVjZqa3
Competition Assessment: Immunosuppresant Drug Monitering Market
Some of the players in the global immunosuppressant drug monitoring market include:
• Thermo Fisher Scientific (U.S.)
• Hoffmann-La Roche AG (Switzerland)
• Bio-Rad Laboratories Inc. (U.S.)
• Abbott Laboratories (U.S.)
• Siemens Healthcare (Germany)
• Danaher Corporation (U.S.).
Notable Market Developments: Immunosuppresant Drug Monitering Market
• In July 2013, Roche launched Elecsys Tcrolimus and Cyclosporine test, a high TDM tests for immunosuppressant drugs tacrolimus and cyclosporine.
Key Features of the Report:
• The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/immunosuppressant-drug-monitoring-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunosuppressant Drug Monitoring Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023 here
News-ID: 998262 • Views: …
More Releases from Precision Business Insights
Biochar Market Growth Is Attributed To The Increased Production Of Biochar Throu …
According to Precision Business Insights (PBI), the latest report biochar market was valued at USD 243.8 million in 2022, growing at a 12.6% CAGR during the forecast period 2023 to 2029. The rising demand for organic and eco-friendly products drives the biochar market. Utilizing biochar corresponds with organic farming methods, improving market prospects. Furthermore, biochar is a potential material for water treatment and remediation because of its capacity to absorb…
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Me …
According to Precision Business Insights (PBI), latest report vapor recovery units market was valued at USD 923.7 million in 2022 and is poised to grow at a CAGR of 4.2% during the forecast period 2023 to 2029. The adoption of stringent environmental regulations by governments and international bodies to reduce air pollution and greenhouse gas emissions in various countries drives the demand for the vapor recovery unit's market. Furthermore, the…
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
According to Precision Business Insights (PBI), latest report pyrite market is growing at 4.9% CAGR during the forecast period 2023 to 2029. The increased application of pyrite in the manufacturing of sulfuric acid drives the pyrite market. The increase of prices of gold has led to increased demand for imitation jewelry which is anticipated to propel the pyrite market growth. Furthermore, the demand for sulphuric acid in a variety of…
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Gen …
According to Precision Business Insights (PBI), the latest report industrial boilers market size was valued at USD 15,261.8 million in 2022 and is poised to grow at a 3.1% CAGR during the forecast period 2023 to 2029. The adoption of stringent environmental regulations to maintain emission standards and carbon reduction in several countries drives the industrial boilers market. Furthermore, the advancement in boiler technology, such as better combustion systems, greater…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
